Collegium Pharmaceutical Stock Price. Everything You Need To Know About The Collegium Pharmaceutical Stock!
Collegium Pharmaceutical, Inc. operates as a pharmaceutical company. The company is headquartered in Stoughton, Massachusetts and currently employs 207 full-time employees. The company went IPO on 2015-05-07. The firm commercializes its pain portfolio, consisting of Xtampza extended-release (ER), Nucynta Products, Belbuca, and Symproic in the United States. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone. Xtampza ER is for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The Nucynta Products are extended-release (ER) and immediate-release (IR) formulations of tapentadol. Nucynta ER is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. Nucynta IR is indicated for the management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate in adults. Belbuca is a buccal film that contains buprenorphine, a partial opioid agonist. Symproic is an oral formulation of naldemedine.
Collegium Pharmaceutical Stock Price. Everything You Need To Know About The Collegium Pharmaceutical Stock! performance
- Employees 207
- Company HQ Stoughton
- Website https://www.collegiumpharma.com/
- COLL Asset Type Common Stock
- COLL Market Capitalization 1.2B
- Earnings Per Share 1.29
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 51.98
Are you interested in investing in the stock market from Malaysia, Thailand, Indonesia, or Vietnam? Look no further than Collegium Pharmaceutical – a promising stock that deserves your attention. Collegium Pharmaceutical is a cutting-edge company in the healthcare industry, specializing in developing abuse-deterrent products for pain management. With their innovative portfolio and revolutionary technology, Collegium Pharmaceutical is revolutionizing the way we approach pain medication. If you’re considering investing in this stock, Zorion is here to guide you through the process. Our platform offers investment insights, recommendations, and educational resources specifically tailored to retail investors from Malaysia, Thailand, Indonesia, and Vietnam. Expand your investment knowledge and make informed decisions with Zorion. Start investing in Collegium Pharmaceutical today to secure a brighter financial future.
